A high-level overview of Aytu BioPharma, Inc. (AYTU) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Best Stock Chat Rooms, Message Board, And Forums—Our Top Picks. Best Chat Room. Best Message Board. Best Forum. Trade Ideas. Motley Fool Stock Advisor (And Other Services) Bogleheads. 4.7. 4.7. 4.4. Standard: $1,068/yr. Premium: $2,136/yr. Discount with code in box below. $89/yr. for the first year. Free.The aggregate offering price for each share of common stock or each pre-funded warrant and, in each case, an accompanying common warrant to purchase 1.1 shares of common stock is $1.25.The all-stock transaction is valued, on a fully diluted basis, at approximately $44.9 million based on the 10-day volume weighted average price of Aytu stock for the period ended December 9, 2020. The boards of directors of both companies have approved the transaction.Aytu BioScience, Inc. ("the Company" or "Aytu") Board of Directors approved a 1-for-10 reverse stock split of the Company's common stock, which will be effective at 8:00 a.m. Eastern Time on Tuesday, December 8, 2020. The Company's stockholders approved the reverse stock split at an Annual Meeting of Stockholders on April 23, 2020.Shares of Aytu Biopharma Inc (AYTU) dropped by 22.11% from $2.94 to $2.29 in the trading on Wednesday, Novemeber 15, 2023. The reason why AYTU is down today is due to weak quarterly results. In the first quarter of fiscal 2024, AYTU reported total net revenue of $22.1 million, down from $27.7 million in the previous year. This decline …STOCK SUMMARY. Symbol: NASDAQ:AYTU. Price: (As of 1/4/18) $2.55. Market Cap: (1/4/18) $ 12.7 million. MANAGEMENT TEAM. Josh Disbrow. Chairman & Chief Executive Officer. ... Prior to forming Aytu BioScience, Josh was the Chief Operating Officer of Ampio Pharmaceuticals (NYSE MKT: AMPE) and led the Luoxis Diagnostics subsidiary. ...Find the latest Aytu BioPharma, Inc. (0A8M.L) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Aytu Biopharma (0A8M) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more.So Aytu BioPharma, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Aytu BioPharma, Inc. stock shows the sell signal.DENVER, CO / ACCESSWIRE / November 7, 2023 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, will report financial results for its first quarter of fiscal year 2024 for the period ended September 30, 2023, after the market close on Tuesday, November 14, 2023. The Company has scheduled a conference call that ...Aytu BioScience, Inc.'s Growth. Aytu BioScience, Inc. has seen its earnings per share (EPS) increase by 156% a year over the past three years. Its revenue is up 489% over the last year.Review the current valuation for Aytu BioPharma Inc (AYTU:XNAS) stock based on a yearly calendar providing PE ratios, cash flow, EBITDA and other company valuation information.The Company's shares of common stock will continue to trade on the NASDAQ under the symbol "AYTU." The new CUSIP number for the Company's common stock post-reverse stock split is 054754858.Aytu BioPharma ( NASDAQ: AYTU) announced on Friday the pricing of its equity offering of 1.7M shares of its common stock and accompanying Tranche A and Tranche B warrants to purchase 4.3M shares ...Find the latest Aytu BioScience Inc. (AYTU) discussion and analysis from iHub's community of investors.The average one-year price target for Aytu BioPharma (NasdaqCM:AYTU) has been revised to 8.16 / share. This is an increase of 60.00% from the prior estimate of 5.10 dated January 16, 2024.View the latest Aytu BioPharma Inc. (AYTU) stock price, news, historical charts, analyst ratings and financial information from WSJ.View the AYTU premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Aytu BioScience Inc real time stock price chart below. You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on ...The Aytu BioPharma Inc (AYTU) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $79.62, representing a +2,388% increase from the current price of $3.20.The highest analyst price target is $73.17, and the lowest is $86.06.The best stock chat room, message board, or forum for you depends on factors such as whether you’re a serious or casual trader, your budget, and any other tools/services you might want. Casual traders, with low budgets, who are solely interested in the chats should consider TradingView , Bogleheads , Trade Ideas (upgrade necessary …What's Happening With AYTU Stock Today? Aytu Biopharma Inc (AYTU) stock is trading at $1.59 as of 11:52 AM on Monday, Dec 13, a loss of -$0.12, or -7.02% from the previous closing price of $1.71. The stock has traded between $1.57 and $1.71 so far today. Volume today is high. So far 1,060,686 shares have traded compared to average volume of ...Free AYTU Stock Alerts. $3.15. +0.04 (+1.29%) (As of 05/31/2024 ET) Compare. Share. Today's Range. $3.13. . $3.19. 50-Day Range. $2.67. . $3.36. 52-Week …AYTU Stock Earnings: Aytu Misses EPS, Revenue Estimates Aytu lost $1.93 per share May 11, 2023 By Sarah Smith , Editor-in-Chief, InvestorPlace.com May 11, 2023, 4:25 pm EST May 11, 2023Get Aytu Biopharma Inc (AYTU.MW) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsThe company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which it generates maximum revenue from the Rx segment. In depth view into AYTU (Aytu BioPharma) stock including the latest price, news, dividend history, earnings information and financials.Form 4. Statement of changes in beneficial ownership of securities. 06/23/2023. 3:54 PM. Aytu BioPharma (Filer) Form S-8. Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans. 06/22/2023.Top 100 Most Viewed Boards Today. Today This Week Last Week This Month Last Month. 1. CYDY CytoDyn Inc (15000) 2. The Bridge (3063) 3. SHEEPWOLF'S $1,000,000.00 JOURNEY (2961) 4.Find the latest Vistagen Therapeutics, Inc. (VTGN) stock quote, history, news and other vital information to help you with your stock trading and investing.Net Loss: Reduced to $2.9 million or $0.52 per share from $7.2 million or $1.93 per share year-over-year. Consumer Health Segment Revenue: Declined from $8.9 million to $4 million as the segment ...What is Aytu BioPharma's stock forecast and purchase recommendation? According to the research reports of 1 Wall Street equities research analysts, the average twelve-month stock price forecast for Aytu BioPharma is $5.00, with a high forecast of $5.00 and a low forecast of $5.00. The consensus rating for Aytu BioPharma stock is Buy based on ...Upon the effectiveness of the merger, Neos stockholders will be entitled to receive 0.1088 shares of common stock of Aytu for each share of Neos common stock held, after taking into account the one-for-ten reverse split of Aytu's common stock that was effected on December 8, 2020. ... The Boards of Directors of both companies have approved the ...aytubio.com. Aytu Biopharma, Inc., a commercial-stage pharmaceutical company, focuses on commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company operates through two segments: Rx segment and Consumer Health segment.Find the latest SEC Filings data for Aytu BioPharma, Inc. Common Stock (AYTU) at Nasdaq.com.Aytu BioPharma, Inc. Denver Corporate Center III 7900 E. Union Avenue, Suite 920 Denver, CO 80237 +1 (855) AYTU BIO (+1 855-298-8246)Aytu Biopharma (NASDAQ:AYTU) just posted results for its fiscal third quarter. Aytu reported a loss per share of $1.93. This was much worse than the analyst estimate for a loss per share of 63 ...The reverse stock split, which was approved by the company's stockholders in June, will reduce the number of outstanding common stock to about 1.8 million shares from about 35.9 million shares. In April, Aytu received a noncompliance notice from Nasdaq Stock Market for failing to meet the $1 minimum bid price listing requirement.The all-stock transaction is valued, on a fully diluted basis, at approximately $44.9 million based on the 10-day volume weighted average price of Aytu stock for the period ended December 9, 2020.Aytu BioPharma Inc. Annual stock financials by MarketWatch. View the latest AYTU financial statements, income statements and financial ratios.NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of JOYY Inc. (NASDAQ: YY) resulting from allegations that JOYY may have issued materially misleading business in... In case you are interested YY - ROSEN, GLOBALLY ...The all-time high Aytu BioPharma stock closing price was 22600.00 on October 20, 2017. The Aytu BioPharma 52-week high stock price is 3.50, which is 12.5% above the current share price. The Aytu BioPharma 52-week low stock price is 1.38, which is 55.6% below the current share price. The average Aytu BioPharma stock price for the last 52 weeks ...Latest Aytu Biopharma Inc Stock News. As of December 06, 2023, Aytu Biopharma Inc had a $13.7 million market capitalization, putting it in the 16th percentile of companies in the Pharmaceuticals industry. Aytu Biopharma Inc does not have a meaningful P/E due to negative earnings over the last 12 trailing months.Aytu BioScience Inc stock price (AYTU) NASDAQ: AYTU. Buying or selling a stock that's not traded in your local currency? Don't let the currency conversion trip you up. Convert Aytu BioScience Inc stocks or shares into any currency with our handy tool, and you'll always know what you're getting. Select a stock.Find the latest Biocept, Inc. (BIOC) stock quote, history, news and other vital information to help you with your stock trading and investing. ... AYTU Aytu BioPharma, Inc. 3.0314A high-level overview of Capricor Therapeutics, Inc. (CAPR) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.First Safety Study Utilizing Ultraviolet A Light Catheter as a Prospective Anti-Infective in Critically Ill, Intubated SARS-Cov-2 Patients. ENGLEWOOD, CO / ACCESSWIRE / December 28, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company (the 'Company') focused on commercializing novel products that address significant patient needs announced the completion of the safety ...ENGLEWOOD, CO / ACCESSWIRE / March 22, 2021 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel therapeutics and consumer healthcare products, today announced the closing of its merger with Neos Therapeutics (previously trading on Nasdaq under "NEOS"). The combined, publicly traded company ...Aytu BioPharma, Inc. Denver Corporate Center III 7900 E. Union Avenue, Suite 920 Denver, CO 80237 +1 (855) AYTU BIO (+1 855-298-8246)Get Aytu Biopharma Inc (AYTU.MW) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsAYTU AYTU BioPharma Inc Amended Annual Report (10-k/a) 0001385818--06-302021FYfalse00013858182020-12-3100013858182021-09-1000013858182020-07-012021-06-30xbrli:sharesiso4217:USD UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,...May 19, 2024 · Get Aytu Biopharma Inc (AYTU.A) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsDiscuss the Biotech industry here. Message board - Online Community of active, educated investors researching and discussing Discuss the Biotech industry here. Stocks.Stock Charts Stock Screener Analyzer Market Monitor Sectors Insider Trading Up- and Downgrades; ... On top of that, AYTU also shows a nice and consistent pattern of rising prices. AYTU is one of the better performing stocks in the Pharmaceuticals industry, it outperforms 77% of 197 stocks in the same industry.The latest Aytu BioPharma stock prices, stock quotes, news, and AYTU history to help you invest and trade smarter.Aytu BioPharma (AYTU) priced its underwritten public offering of 21.5M shares to certain investors, pre-funded warrants to purchase 1.75M shares and accompanying warrants to purchase...This would represent a 4,736.33% increase in the AYTU stock price. Aytu BioScience Stock Prediction 2030. In 2030, the Aytu BioScience stock will reach $ 40.95B if it maintains its current 10-year average growth rate. If this Aytu BioScience stock prediction for 2030 materializes, AYTU stock will grow 1,279,668,883,419.68% from its current price.Projects that involve Hardie Boards often require different cuts; it is almost like a prerequisite. Such a board, however, is not easy to cut and requires Expert Advice On Improvin...Get the latest Aytu Biopharma Inc (AYTU) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment …You can find many images and animated files on the Internet, and you can put these files on your cell phone for use in text messages. Sending the animated file from your computer t.../ Aytu BioPharma, Inc. (the "Company" or "Aytu") (NASDAQ:AYTU), a commercial stage pharmaceutical and consumer health company providing pediatric-focused prescription drugs and cost-effective ...Aytu Bioscience Stock News . OTC Markets Group > Healthcare > Drug Manufacturers—Specialty & Generic Open Broker Account $2.96 -0.100 (-3.27%) ... Aytu BioPharma, Inc. (NASDAQ:AYTU ) Q3 2023 Earnings Conference Call May 11, 2023 4:30 PM ET Company Participants Roger Weiss - Lytham Partners Josh Disbrow - Chief Executive Officer Mark Oki ...Aytu BioPharma, Inc. (NASDAQ:NASDAQ:AYTU) Q4 2023 Earnings Call Transcript September 27, 2023 4:30 PM ETCompany ParticipantsRobert Blum - IRJosh Disbrow -...In 2023, Aytu BioPharma's revenue was $107.40 million, an increase of 11.10% compared to the previous year's $96.67 million. Losses were -$17.05 million, -84.33% less than in 2022. Financial Statements.ABUS Arbutus Biopharma Corporation. 3.3600. +1.20%. Find the latest Altimmune, Inc. (ALT) stock quote, history, news and other vital information to help you with your stock trading and investing.AYTU BioPharma (AYTU) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more.What's Happening with AYTU Stock Today. Aytu Biopharma Inc (AYTU) stock is unmoved 0.9% while the S&P 500 is lower by -2.01% as of 11:49 AM on Thursday, Dec 22. AYTU is unchanged $0.00 from the previous closing price of $0.20 on volume of 413,210 shares. Over the past year the S&P 500 is lower by -19.08% while AYTU is lower by -86.84%.Find the latest Arcadium Lithium plc (ALTM) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.XDSL Stock Message Board for Investors. mPhase Technologies, Inc. Stock Price, News and Company Updates. Message Board Total Posts: 36Through this transaction Aytu has retired all outstanding common stock of Innovus and certain Innovus warrants for consideration consisting of approximately 3.8 million shares of Aytu common stock ...Current Price. $3.11. Options. Overview. Research & Ratings. Notes & Data Providers. Aytu BioPharma Inc. analyst ratings, historical stock prices, earnings estimates & actuals. AYTU updated stock ...Aytu BioPharma Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time AYTU stock price.View Aytu BioPharma, Inc. AYTU stock quote prices, financial information, real-time forecasts, and company news from CNN.Aytu's consumer health segment markets a range of over-the-counter medicines, personal care products, and dietary supplements addressing a range of common conditions including diabetes, allergy ...Aytu BioScience (AYTU)announces the closing of its $44.9M merger with Neos Therapeutics, withNeos merging with a wholly-owned subsidiary of Aytu.The combined company has begun...Behind every co-op is a shady board of puppet masters pulling the very strings of existence, right? While it may seem that way, it's not always so. Take this fact-or-fiction quiz t...Aytu BioScience is set to announce its Q1 earnings results on November 14th after market close.Find the latest Artificial Intelligence Technology Solutions Inc. (AITX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Aytu's consumer health segment markets a range of over-the-counter medicines, personal care products, and dietary supplements addressing a range of common conditions including diabetes, allergy ...At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.